News from the healthcare data industry
In a retrospective cohort study reported in JAMA Network Open, Sanjay Popat, FRCP, PhD, and colleagues found that among patients initiating first-line pembrolizumab for EGFR and ALK wild-type advanced non–small cell lung cancer (NSCLC), ever-smokers had...
Tempus, a leader in artificial intelligence and precision medicine, today announced a collaboration with Intermountain Healthcare, a Utah-based, nonprofit healthcare system, which leverages genomic testing and data analytics to advance...
BD is among the first companies to enter innovative partnership with Mayo Clinic Platform for access to world’s largest collection of clinical data FRANKLIN LAKES, N.J., June 13, 2022 /PRNewswire/ — BD...
June 15, 2022 09:15 AM Eastern Daylight Time ST. LOUIS–(BUSINESS WIRE)–Pierian®, a global leader in advanced clinical genomics technology and services, announced with Syapse®, a leading real-world evidence company, a new joint...
Relative to white patients, racial and ethnic groups saw a sharper decline in access to medicines to treat opioid use disorder during the early stages of the COVID-19 pandemic—intensifying pre-pandemic...
SAN FRANCISCO, June 14, 2022 /PRNewswire/ — Syntegra, a leader in synthetic healthcare data generation, today announced a partnership with TMA Precision Health (TMA), a StartUp Health platform for rare diseases, aimed at using synthetic...
CAMBRIDGE, Mass., June 14, 2022 /PRNewswire/ — TriNetX, LLC, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, today announced that Finnish Biobanks (FINBB), a cooperative...
NEW YORK, NY (June 14, 2022) – New York-based Healthcare technology company, mphrX, today announced its partnership with Mount Sinai Health System (Mount Sinai) to deploy mphrX’s Minerva platform to enable...
In a study reported in a research letter in JAMA Oncology, Nimgaonkar et al found that less than half of patients with urothelial cancer who had received first-line platinum-based therapy underwent...
Teclistamab was found to have improved effectiveness in terms of progression-free survival (PFS), time to next treatment (TTNT), and overall survival (OS) vs real-world physician’s choice of therapy in patients...